Suivre
Adrian Soto-Mota, MD, PhD, FACP.
Adrian Soto-Mota, MD, PhD, FACP.
National Institute of Medical Sciences and Nutrition Salvador Zubiran
Adresse e-mail validée de incmnsz.mx
Titre
Citée par
Citée par
Année
Safety and tolerability of sustained exogenous ketosis using ketone monoester drinks for 28 days in healthy adults
A Soto-Mota, H Vansant, RD Evans, K Clarke
Regulatory Toxicology and Pharmacology 109, 104506, 2019
852019
Why a d-β-hydroxybutyrate monoester?
A Soto-Mota, NG Norwitz, K Clarke
Biochemical Society Transactions 48 (1), 51-59, 2020
652020
Multi-loop model of Alzheimer disease: an integrated perspective on the Wnt/GSK3β, α-synuclein, and type 3 diabetes hypotheses
NG Norwitz, AS Mota, SG Norwitz, K Clarke
Frontiers in Aging Neuroscience 11, 184, 2019
372019
Elevated LDL cholesterol with a carbohydrate-restricted diet: evidence for a “lean mass hyper-responder” phenotype
NG Norwitz, D Feldman, A Soto-Mota, T Kalayjian, DS Ludwig
Current Developments in Nutrition 6 (1), nzab144, 2022
352022
The low‐harm score for predicting mortality in patients diagnosed with COVID‐19: a multicentric validation study
A Soto‐Mota, BA Marfil‐Garza, E Martínez Rodríguez, ...
Journal of the American College of Emergency Physicians Open 1 (6), 1436-1443, 2020
292020
Stroke in systemic lupus erythematosus: epidemiology, mechanism, and long-term outcome
P Guraieb-Chahín, C Cantú-Brito, A Soto-Mota, L Guerrero-Torres, ...
Lupus 29 (5), 437-445, 2020
282020
LRP5, bone density, and mechanical stress: a case report and literature review
NG Norwitz, AS Mota, M Misra, KE Ackerman
Frontiers in endocrinology 10, 452741, 2019
262019
Exogenous ketosis in patients with type 2 diabetes: Safety, tolerability and effect on glycaemic control
A Soto‐Mota, NG Norwitz, R Evans, K Clarke, TM Barber
Endocrinology, Diabetes & Metabolism 4 (3), e00264, 2021
252021
Exogenous d‐β‐hydroxybutyrate lowers blood glucose in part by decreasing the availability of L‐alanine for gluconeogenesis
A Soto‐Mota, NG Norwitz, RD Evans, K Clarke
Endocrinology, Diabetes & Metabolism 5 (1), e00300, 2022
192022
Ketotherapeutics for neurodegenerative diseases
NG Norwitz, JG Jaramillo, K Clarke, A Soto
International review of neurobiology 155, 141-168, 2020
182020
Ketones: potential to achieve brain energy rescue and sustain cognitive health during ageing
É Myette-Côté, A Soto-Mota, SC Cunnane
British Journal of Nutrition 128 (3), 407-423, 2022
172022
The lipid energy model: reimagining lipoprotein function in the context of carbohydrate-restricted diets
NG Norwitz, A Soto-Mota, B Kaplan, DS Ludwig, M Budoff, A Kontush, ...
Metabolites 12 (5), 460, 2022
172022
Prospective predictive performance comparison between clinical gestalt and validated COVID-19 mortality scores
A Soto-Mota, BA Marfil-Garza, S Castiello-de Obeso, ...
Journal of Investigative Medicine 70 (2), 415-420, 2022
172022
Restricting carbohydrates and calories in the treatment of type 2 diabetes: a systematic review of the effectiveness of ‘low-carbohydrate’interventions with differing energy levels
AP Nicholas, A Soto-Mota, H Lambert, AL Collins
Journal of nutritional science 10, e76, 2021
142021
Impact of healthcare strain on access to mechanical ventilation and mortality of hospitalized COVID-19 patients: a retrospective cohort study
I Núñez, A Soto-Mota
Transactions of The Royal Society of Tropical Medicine and Hygiene 117 (5 …, 2023
122023
The effects of endogenously‐and exogenously‐induced hyperketonemia on exercise performance and adaptation
DJ Dearlove, A Soto Mota, D Hauton, K Pinnick, R Evans, J Miller, ...
Physiological Reports 10 (10), e15309, 2022
82022
COVID-19 pandemic and the consequential effect on patients with endometriosis
MS Ashkenazi, OL Huseby, G Kroken, A Soto-Mota, M Pents, A Loschiavo, ...
Human Reproduction Open 2022 (2), hoac013, 2022
82022
Evidence for the carbohydrate–insulin model in a reanalysis of the Diet Intervention Examining The Factors Interacting with Treatment Success (DIETFITS) trial
A Soto-Mota, MA Pereira, CB Ebbeling, L Aronica, DS Ludwig
The American Journal of Clinical Nutrition 117 (3), 599-606, 2023
72023
Elevated LDL-cholesterol levels among lean mass hyper-responders on low-carbohydrate ketogenic diets deserve urgent clinical attention and further research
NG Norwitz, MR Mindrum, P Giral, A Kontush, A Soto-Mota, TR Wood, ...
Journal of Clinical Lipidology 16 (6), 765-768, 2022
72022
Case report: Hypercholesterolemia “Lean Mass Hyper-Responder” phenotype presents in the context of a low saturated fat carbohydrate-restricted diet
NG Norwitz, A Soto-Mota, D Feldman, S Parpos, M Budoff
Frontiers in Endocrinology 13, 830325, 2022
62022
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20